Doi.org/10.1016/j.jaad.2014.10.025
Revision as of 04:26, 4 August 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR]) ; Kim Papp Alice B Gottlieb Luigi Naldi David Pariser Vincent Ho Kavitha Goyal Steven Fakharzade; NULL; 01/09/2015; https://doi.org/10.1016/j.jaad.2014.10.025 == Reasons == Note: Reasons not yet here included, but you are welcome to insert this information wheneve...")
Target Article[edit | edit source]
Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR]) ; Kim Papp Alice B Gottlieb Luigi Naldi David Pariser Vincent Ho Kavitha Goyal Steven Fakharzade; NULL; 01/09/2015; https://doi.org/10.1016/j.jaad.2014.10.025
Reasons[edit | edit source]
Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.